Results 141 to 150 of about 4,533 (250)

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.

open access: yes, 2004
Fabry's disease is an X-linked lysosomal storage disease caused by a deficiency of alpha-galactosidase that results in an accumulation of neutral glycosphingolipids throughout the body, including the cardiovascular system.
Andreucci MV.   +8 more
core  

Prenatal Identification of an EDA Variant in Dichorionic Male Twins: CfDNA Signal with Invasive Confirmation. [PDF]

open access: yesGenes (Basel)
Marcella S   +14 more
europepmc   +1 more source

Cutaneous manifestations of Fabry disease: A systematic review. [PDF]

open access: yesJ Dermatol
Al-Chaer RN   +4 more
europepmc   +1 more source

Oligodontia Management in a Resource-Limited Setting: Two Case Reports and Review of Literature. [PDF]

open access: yesCase Rep Dent
Malami AB   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy